| Home | E-Submission | Sitemap | Contact Us |  
top_img
Journal of the Korean Neurological Association 2013;31(3): 143-157.
2013년 한국뇌졸중진료지침 개정과 근거에 대한 고찰
홍근식, 유경호 a 나정호 b 김한영 c 구자성 d 박종무 e 서대희 f 박인성 g 조경희 h 정근화 i 박태환 j 이병철 a 윤병우 I
인제대학교 의과대학 일산백병원 신경과, 한림대학교 의과대학 신경과학교실 , 인하대학교 의과대학 신경과학교실 , 건국대학교 의학 전문대학 신경과학교실 c , 가톨릭대학교 의과대학 신경과학교실 d , 을지대학교 의과대학 신경과학교실 e , 굿모닝병원 신경외과 f , 경상대학 교 의학전문대학원 신경외과학교실 g , 고려대학교 의과대학 신경과학교실 h , 서울대학교 의과대학 신경과학교실 i , 서울의료원 신경과 j
Review of Evidences and Updates of the Korean Clinical Practice Guidelines for Stroke in 2013
Keun-Sik Hong
Department of Neurology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea Department of Neurology a , Hallym University College of Medicine, Anyang, Korea Department of Neurology b , Inha University College of Medicine, Incheon, Korea Department of Neurology c , Konkuk University School of Medicine, Seoul, Korea Department of Neurology d , The Catholic University of Korea College of Medicine, Seoul, Korea Department of Neurology e , Eulji University College of Medicine, Seoul, Korea Department of Neurosurgery f , Good Morning Hospital, Pyeongtaek, Korea Department of Neurosurgery g , Gyeongsang National University School of Medicine, Jinju, Korea, Department of Neurology h , Korea University College of Medicine, Seoul, Korea Department of Neurology i , Seoul National University College of Medicine, Seoul, Korea Department of Neurology j , Seoul Medical Center, Seoul, Korea
Abstract
The first edition of Korean Clinical Practice Guidelines for Stroke, which was published in 2009, reflected evidence published prior to June 2007. Since then, many clinical trials and well-designed observational studies provided new evidence that may be pertinent to clinical practice. Accordingly, investigators of the Clinical Research Center for Stroke have timely updated the guidelines. This article summarizes the recent evidence and updated guidelines regarding the use of aspirin for primary stroke prevention, the management of asymptomatic carotid stenosis, the use of antithrombotics in atrial fibrillation for stroke prevention, the diagnosis and management of unruptured aneurysm, intravenous and intra-arterial thrombolysis in acute ischemic stroke, antiplatelet therapy for secondary stroke prevention in patients with non-cardioembolic stroke or transient ischemic attack, and the management of symptomatic carotid stenosis for secondary stroke prevention. Key Words: Stroke, Guidelines, Evidence